Powered by artificial intelligence, the new Ultrasound Workspace platform reportedly offers advanced echocardiography capabilities and facilitates enhanced diagnostic workflows.
In what may be a significant advance in echocardiography analysis and reporting across multiple systems, Philips launched the Ultrasound Workspace platform at the American College of Cardiology’s Annual Scientific Session and Expo (ACC 2022).
Combining 3D echocardiography capabilities with artificial intelligence (AI)-driven analysis and quantification tools, the Ultrasound Workspace also bolsters connectivity and reporting across different systems with vendor-neutral applications and remote browser access, according to Philips.
“We have combined the power of AI with deep clinical knowledge to create a solution that integrates into the workflows of healthcare providers to help drive efficient clinical decision-making,” noted Jeff Cohen, the senior vice president and global business leader of ultrasound for Philips. “With Ultrasound Workspace, our customers can experience a whole new world of echocardiography workflow to help improve both the patient and staff experience.”
Incorporating quality standards from the American Society of Echocardiography (ASE) and Intersocietal Accreditation Commission (IAC), Philips said the Ultrasound Workspace builds upon the capabilities of Philips’ ultrasound system EPIQ CV with improved efficiency and diagnostic confidence of quantitative measurements such as left ventricular ejection fraction.
Offering flexible licensing for facilities large and small, Philips noted that Ultrasound Workspace is a scalable platform that can be utilized as a stand-alone solution or incorporated into existing PACS and EMR echocardiography workflows.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.